Skip to main content
Premium Trial:

Request an Annual Quote

Stilla Technologies: Philippe Mourere, Rémi Dangla

Stilla Technologies has appointed Philippe Mourere as CEO, to replace founder and CEO Rémi Dangla. Mourere has 25 years of diagnostics executive experience at firms such as HalioDx, Ultivue, Cell Signaling Technology, PerkinElmer, and Caliper Life Sciences. Dangla has been appointed Stilla's chief technology officer and remains a member of the board of directors.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.